(Q48073666)

8 February 2018

title

Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge (English)

1 reference

8 February 2018

author

Jasminka Sterjovski

2

1 reference

8 February 2018

Lachlan Gray

5

1 reference

8 February 2018

Marianne Jansson

Marianne Jansson

13

0 references

Adnane Achour

Adnane Achour

11

0 references

Eva Maria Fenyö

10

Eva Maria Fenyö

1 reference

8 February 2018

Jan Albert

9

Jan Albert

1 reference

8 February 2018

Johanna Repits

1

Johanna Repits

1 reference

8 February 2018

Mattias Mild

4

Mattias Mild

1 reference

8 February 2018

author name string

Daniel Badia-Martinez

3

1 reference

8 February 2018

Melissa J Churchill

6

1 reference

8 February 2018

Damian F J Purcell

7

1 reference

8 February 2018

Anders Karlsson

8

1 reference

8 February 2018

Paul R Gorry

12

1 reference

8 February 2018

language of work or name

English

0 references

publication date

30 July 2008

1 reference

8 February 2018

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

8 February 2018

volume

379

1 reference

8 February 2018

issue

1

1 reference

8 February 2018

page(s)

125-134

1 reference

8 February 2018

The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

HIV-1 virion-cell interactions: an electrostatic model of pathogenicity and syncytium formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Pathogenesis of macrophage tropic HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

HIV-1 envelope determinants for cell tropism and chemokine receptor use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Structure of a V3-containing HIV-1 gp120 core

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

A prospective study of 115 initially asymptomatic HIV infected gay men in Stockholm, Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Mt-2 Cell Tropism Of Human Immunodeficiency Virus Type 1 Isolates As A Marker For Response To Treatment And Development Of Drug Resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

MEGA2: molecular evolutionary genetics analysis software

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Increased In Vitro Cytopathicity of CC Chemokine Receptor 5–Restricted Human Immunodeficiency Virus Type 1 Primary Isolates Correlates with a Progressive Clinical Course of Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

HIV evolution: CTL escape mutation and reversion after transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

MODELTEST: testing the model of DNA substitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

HIV-1 entry inhibitors: classes, applications and factors affecting potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

The host environment drives HIV-1 fitness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

A statistical characterization of consistent patterns of human immunodeficiency virus evolution within infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

The antigenic structure of the HIV gp120 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

DAMBE: software package for data analysis in molecular biology and evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.06.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2008.06.014

1 reference

8 February 2018

1 reference

8 February 2018